# Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

> **NCT05937438** · PHASE1,PHASE2 · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Esophageal Carcinoma

## Interventions

- **DRUG:** Immune Checkpoint Inhibitors

## Key facts

- **NCT ID:** NCT05937438
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05937438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05937438, "Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05937438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*